ArticleBritish journal of pharmacology2020

OATP1A/1B, CYP3A, ABCB1, and ABCG2 limit oral availability of the NTRK inhibitor larotrectinib, while ABCB1 and ABCG2 also restrict its brain accumulation.

Yaogeng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.